Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SOLIFENACIN | 10MG | TABLET | Actual shortage | 2023-06-19 | 2023-11-03 | 195481 |
| TEVA-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-20 | 2023-07-06 | 195876 |
| TEVA-OLANZAPINE | 10MG | TABLET | Avoided shortage | 2023-07-20 | 2023-08-17 | 199365 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-20 | 2024-01-19 | 199398 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-27 | 2024-01-19 | 200290 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2023-08-18 | 2023-10-04 | 202490 |
| TEVA-SIMVASTATIN | 10MG | TABLET | Actual shortage | 2023-10-05 | 2024-04-25 | 206401 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-10-05 | 2023-11-09 | 206428 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-10-19 | 2023-11-30 | 207506 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209125 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2023-11-23 | 209130 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209133 |
| TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2023-11-09 | 2023-12-14 | 209669 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210434 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211982 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211998 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 212001 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-12-14 | 2024-03-21 | 213374 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-11 | 2024-02-01 | 215731 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-25 | 2024-03-14 | 217229 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |